PTPRD and neoplasm: In this study, the further enrichment of immune signatures, including CD8+ T cells, Tfh, B cells, DCs, cytotoxic activity, and pro-inflammation, were observed in PTPRD/PTPRT mutant cancers, indicated of the formation of an enhanced anti-tumor immune microenvironment (43).